CDC42 and neuroblastoma: In conclusion, miR-149 level was reduced and its overexpression inhibited cell proliferation but promoted cell apoptosis and Dox chemosensitivity in NB, possibly by targeting CDC42 and BCL2, providing new insight into therapeutic target of miR-149 for NB treatment.